Trial Profile
Regulation of Cholesterol Absorption: LDL Cholesterol Response to a Combination of Phytosterols and Ezetimibe (Phyto-3)
Status:
Completed
Phase of Trial:
Phase 0
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary) ; Phytosterols (Primary)
- Indications Hypercholesterolaemia
- Focus Pharmacokinetics
- Acronyms Phyteaux-III
- 02 May 2012 Actual initiation date changed from Apr 2009 to Jun 2009 as reported by ClinicalTrials.gov.
- 18 Jul 2011 Status changed from not yet recruiting to completed.
- 18 Jul 2011 Results published in Circulation.